Niosome-encapsulated clomipramine for transdermal controlled delivery

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 9, 2014, Pages 567-575

  Mohawed, Ola A M ^a   El Ashmoony, M M ^a   Elgazayerly, Omaima N ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Antidepressant; Clomipramine hydrochloride; HPMC; Niosomal gel; Niosomes; Transdermal

Indexed keywords

CLOMIPRAMINE; NIOSOME; POLYSORBATE 20; POLYSORBATE 60; SORBITAN LAURATE; SORBITAN STEARATE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; ERYTHEMA; NONHUMAN; PARTICLE SIZE; RAT; THIN FILM HYDRATION TECHNIQUE; TOXICITY TESTING; TRANSDERMAL DRUG DELIVERY SYSTEM; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84907857323     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Verma P, Chandak R. Development of matrix controlled transdermal delivery systems of pentazocine: in vitro/in vivo performance. Acta Pharm 2009;59:171-86.
2. Pavelic Z, Skalko-Basnet N, Schubert R. Liposomal gels for vaginal drug delivery. Int J Pharm 2001;219:139-49.
3. Chandak AR, Verma PRP. Design and development of hydroxypropyl methycellulose (HPMC) based polymeric films of methotrexate: physicochemical and pharmacokinetic evaluations. Yakugaku Zasshi 2008;128:1057-66.
4. Valenta C, Auner BG. The use of polymers for dermal and transdermal delivery. Eur J Pharm Biopharm 2004;58:279-89.
5. Manosroi A, Khanrin P, Lohcharoenkal W, Werner RG, Friedrich G, Manosroi W, et al. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm 2010;392:304-10.
6. Manconi M, Sinico C, Donatella V, Loy G, Fadda AM. Niosomes as carriers for tritenoin. I. Preparation and prosperities. Int J Pharm 2002;234:237-48.
7. Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra JA. Advances in transcutaneous vaccine delivery: do all ways lead to Rome? J Control Release 2010;148:266-82.
8. Dufes C, Gaillard F, Uchegbu IF, Schatzlein AG, Olivier JC, Muller JM. Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain. Int J Pharm 2004;285:77-85.
9. Rentel CO, Bouwstra JA, Naisbett B, Junginger HE. Niosomes as a novel peroral vaccine delivery system. Int J Pharm 1999;186:161-7.
10. Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 2005;306:71-82.
11. Marianecci C, Paolino D, Celia C, Fresta M, Carafa M, Alhaique F. Nonionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release 2010;147:127-35.
12. Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 2005;59:485-90.
13. Muzzalupo R, Tavano L, Cassano R, Trombino S, Ferrarelli T, Picci N. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Eur J Pharm Biopharm 2011;79:28-35.
14. Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino MC, Biggio G, et al. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle–skin interaction. Eur J Pharm Biopharm 2011;78:27-35.
15. Mura S, Manconi M, Sinico C, Valenti D, Fadda AM. Penetration enhancer containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm 2009;380:72-9.
16. Sweetman SC. Martindale: the Complete Drug Reference. 37th ed. London: Pharmaceutical Press; 2011. p. 417.
17. Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001;228:43-52.
18. Patel KK, Kumar P, Thakkar HP. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS Pharm Sci Tech 2012;13:1502-10.
19. Kallinteri P, Antimisiaris S, Karnabatidis D, Kalogeropoulou C, Tsota I, Siablis D. Dexamethasone incorporating liposomes: an in vitro study of their applicability as a slow releasing delivery system of dexamethasone from covered metallic stents. Biomaterials 2002;23:4819-26.
20. Manosroi A, Kongkaneramit L, Manosroi J. Stability and transdermal absorption of topical amphotericin B liposome formulations. Int J Pharm 2004;270:279-86.
21. Fang JY, Hong CT, Chiu WT, Wang YY. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 2001;219:61-72.
22. Ruckmani K, Jayakar B, Ghosal SK. Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemia: encapsulation, storage and in vitro release. Drug Dev Ind Pharm 2000;26:217-22.
23. Jain RL, Shastri JP. Study of ocular drug delivery system using drug-loaded liposomes. Int J Pharm Investig 2011;1:35-41.
24. Ramana M, Chaudhari A, Himaja M, Satyanarayana D, Dua K. An approach to minimize pseudomembranous colitis caused by clindamycin through liposomal formulation. Indian J Pharm Sci 2007;69:390-93.
25. Zheng-hong W, Qi-neng P, Yi W, Jia-ming L. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. Acta Pharmacol Sin 2004;25:966-72.
26. El-Gazayerly ON, Hikal AH. Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm 1997;158:121-7.
27. Junyaprasert VB, Manwiwattanakul G. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions. Int J Pharm 2008;352:81-91.
28. El-Samaligy M, Afifi N, Mahmoud E. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 2006;308:140-8.
29. Khan KA. The concept of dissolution efficiency. J Pharmacol 1975;27:98-9.
30. Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 2011;405:142-52.
31. Shah S, Rahul J, Prabhakar P. Formulation and evaluation of transdermal patches of papaverine hydrochloride. Asian J Pharm 2010;4:79-86.
32. Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 2008;363:132-8.
33. Uchegbu IF, Vyas SP. Nonionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998;172:33-70.
34. Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, Kim DD, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 2009;377:1-8.
35. Fang SC, Pei Y. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on rehab surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J Pharm Sci 2006;95:1873-87.
36. Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002;224:73-80.
37. Raja Naresh RA, Pillai GK, Udupa N, Chandrashekar G. Antiinflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian J Pharmacol 1994;26:46-8.
38. Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS Pharm Sci Tech 2010;11:1119-27.
39. Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan trimester (Span 85). Int J Pharm 1994;105:1-6.
40. Kibbe AH, editor. Handbook of Pharmaceutical Excepients, 3rd ed. American Pharmaceutical Association: Washington, DC; 2000. p. 511-4.
41. Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target 2009;17:671-89.
42. Hao YM, Li K. Entrapment and release difference resulting from hydrogen bonding interactions in niosomes. Int J Pharm 2011;403:245-53.
43. Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various non ionic surfactants for paclitaxel oral delivery. J Pharm Sci 2010;99:2049-60.
44. Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 2008;25:499-512.
45. Devaraj GN, Parakh SR, Devraj R, Apte SS, Rao BR, Rambhau D. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci 2002;251:360-5.
46. Liu T, Guo R, Hua W, Qui J. Structure behaviors of hemoglobin in PEG6000/Tween80/Span80/H2O niosome system. Colloids Surf A: Physicochem Eng Aspects 2007;293:255-61.
47. Duxbury MS, Whang EE. RNA interference: a practical approach. J Surg Res 2004;117:339-44.
48. Blazek-Welsh AI, Rhodes DG. Maltodextrin-based proniosomes. AAPS Pharm Sci 2001;3:1-8.
49. Muzzalupo R, Trombino S, Iemma F, Puoci F, La Mesa C, Picci N. Preparation and characterization of bolaform surfactant vesicles. Colloids Surf B: Biointerfaces 2005;46:78-83.
50. Rania MH, Samar M, Nahed DM, Ahmed SG. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharm Sci Tech 2007;8:1-12.
51. Hathout RM, Mansour S, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for Acetazolamide: In vitro and In vivo Studies. AAPS Pharm Sci Tech 2007;8 Suppl 1.
52. Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, Abe M. Characterization of vesicles prepared with various non ionic surfactants mixed with cholesterol. Colloids Surf B: Biointerfaces 2003;30:129-38.
53. Hosny KM. Ciprofloxacin as ocular liposomal hydrogel. AAPS Pharm Sci Tech 2010;11:241-6.
54. Nagarsenker MS, Londhea VY, Nadkarnib GD. Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. Int J Pharm 1999;190 Suppl 1:63-71.
55. Nagarsenker MS, Joshi AA. Preparation, characterization and evaluation of liposomal dispersions of lidocaine. Drug Dev Ind Pharmacy 1997;23 Suppl 12:1159-65.
56. Cocera M, Lopez O, Coderch L, Parra JL, de la Maza A. Permeability investigations of phospholipids liposomes by adding cholesterol. Colloids Surf A: Physicochem Eng Aspects 2003;221:9-17.
57. Abdelbary G, El-gendy N. Niosome-Encapsulated gentamicin for ophthalmic controlled delivery. AAPS Pharm Sci Tech 2008;9 Suppl 3:740-7.
58. Rama Rao K. Microencapsulation of zidovudine by double emulsion solvent diffusion technique using ethyl cellulose. Indian J Pharm Sci 2007;69:244-50.
59. Hoare TR, Kohane DS. Hydrogels in drug delivery: progress and challenges. Polymer 2008;49:1993-2007.